These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8098084)

  • 1. tPA fast by GUSTO.
    Horton R
    Lancet; 1993 May; 341(8854):1188. PubMed ID: 8098084
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GUSTO trial: is the open-artery hypothesis proven?
    Stringer KA; Lindenfeld J
    Ann Pharmacother; 1994 Jan; 28(1):97-8. PubMed ID: 8123971
    [No Abstract]   [Full Text] [Related]  

  • 4. Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
    Van de Werf F; Topol EJ; Lee KL; Woodlief LH; Granger CB; Armstrong PW; Barbash GI; Hampton JR; Guerci A; Simes RJ
    JAMA; 1995 May 24-31; 273(20):1586-91. PubMed ID: 7745771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
    GUSTO investigators
    N Engl J Med; 1993 Sep; 329(10):673-82. PubMed ID: 8204123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of thrombolytic therapy for individual patients: development of a clinical model. GUSTO-I Investigators.
    Califf RM; Woodlief LH; Harrell FE; Lee KL; White HD; Guerci A; Barbash GI; Simes RJ; Weaver WD; Simoons ML; Topol EJ
    Am Heart J; 1997 Jun; 133(6):630-9. PubMed ID: 9200390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial. GUSTO-I Investigators.
    Califf RM; White HD; Van de Werf F; Sadowski Z; Armstrong PW; Vahanian A; Simoons ML; Simes RJ; Lee KL; Topol EJ
    Circulation; 1996 Sep; 94(6):1233-8. PubMed ID: 8822974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-month survival in 20,891 patients with acute myocardial infarction randomized between alteplase and streptokinase with or without heparin. GISSI-2 and International Study Group. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto.
    Eur Heart J; 1992 Dec; 13(12):1692-7. PubMed ID: 1289101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin. The International Study Group.
    Lancet; 1990 Jul; 336(8707):71-5. PubMed ID: 1975322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A randomized study of streptokinase and recombinant tissue plasminogen activator, with and without heparin, in patients with acute myocardial infarction. The results of GISSI-2/International tPA/SK Mortality Trial].
    Steffensen R; Sandøe E
    Ugeskr Laeger; 1991 Oct; 153(41):2880-3. PubMed ID: 1949301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic lidocaine use in acute myocardial infarction: incidence and outcomes from two international trials. The GUSTO-I and GUSTO-IIb Investigators.
    Alexander JH; Granger CB; Sadowski Z; Aylward PE; White HD; Thompson TD; Califf RM; Topol EJ
    Am Heart J; 1999 May; 137(5):799-805. PubMed ID: 10220627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
    GUSTO Angiographic Investigators
    N Engl J Med; 1993 Nov; 329(22):1615-22. PubMed ID: 8232430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Holding GUSTO up to the light. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
    Lee KL; Califf RM; Simes J; Van de Werf F; Topol EJ
    Ann Intern Med; 1994 May; 120(10):876-81; discussion 882-5. PubMed ID: 8154647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute myocardial infarction: is streptokinase really as effective as tissue plasminogen activator?
    Vine DL
    Kans Med; 1990 May; 91(5):147-8. PubMed ID: 2115093
    [No Abstract]   [Full Text] [Related]  

  • 15. GUSTO (Global Utilization of Streptokinase and Tissue plasminogen activator in Occluded arteries): logic wins at last.
    Bassand JP
    Eur Heart J; 1994 Jan; 15(1):2-4. PubMed ID: 8174579
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombolytic therapy for myocardial infarction: a perspective of clinical trialists. The GUSTO Investigators.
    Califf RM; Topol EJ
    Clin Cardiol; 1992 Mar; 15(3):143-4. PubMed ID: 1551260
    [No Abstract]   [Full Text] [Related]  

  • 17. Pitfalls in the economic evaluation of thrombolysis in myocardial infarction. The impact of national differences in the cost of thrombolytics and of differences in the efficacy across patient subgroups.
    Lorenzoni R; Pagano D; Mazzotta G; Rosen SD; Fattore G; De Caterina R; Gensini G
    Eur Heart J; 1998 Oct; 19(10):1518-24. PubMed ID: 9820990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy.
    Baardman T; Hermens WT; Lenderink T; Molhoek GP; Grollier G; Pfisterer M; Simoons ML
    Eur Heart J; 1996 Feb; 17(2):237-46. PubMed ID: 8732377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment after myocardial infarction. Is rapid administration of t-PA + heparin most effective?].
    Wirschubsky Z
    Lakartidningen; 1993 Jun; 90(23):2240. PubMed ID: 8502089
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapy of acute myocardial infarction in the 1990s.
    Flores ED; Lange RA; Cigarroa RG; Hillis LD
    Am J Med Sci; 1990 Jun; 299(6):415-24. PubMed ID: 2113353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.